S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
Rivian (NASDAQ: RIVN) Investors Experience All Four Seasons
Three Techs To Buy Before Santa Comes To Town 
MongoDB Resumes Uptrend, Analyst Raise Targets 
Sportsman’s Warehouse Is A Buy At These Levels 
3 Consumer Staples Stocks to Consider for 2022
EXPLAINER: Chinese builder’s debt struggle rattles investors
Autozone Drives To New High
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
Rivian (NASDAQ: RIVN) Investors Experience All Four Seasons
Three Techs To Buy Before Santa Comes To Town 
MongoDB Resumes Uptrend, Analyst Raise Targets 
Sportsman’s Warehouse Is A Buy At These Levels 
3 Consumer Staples Stocks to Consider for 2022
EXPLAINER: Chinese builder’s debt struggle rattles investors
Autozone Drives To New High
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
Rivian (NASDAQ: RIVN) Investors Experience All Four Seasons
Three Techs To Buy Before Santa Comes To Town 
MongoDB Resumes Uptrend, Analyst Raise Targets 
Sportsman’s Warehouse Is A Buy At These Levels 
3 Consumer Staples Stocks to Consider for 2022
EXPLAINER: Chinese builder’s debt struggle rattles investors
Autozone Drives To New High
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
Rivian (NASDAQ: RIVN) Investors Experience All Four Seasons
Three Techs To Buy Before Santa Comes To Town 
MongoDB Resumes Uptrend, Analyst Raise Targets 
Sportsman’s Warehouse Is A Buy At These Levels 
3 Consumer Staples Stocks to Consider for 2022
EXPLAINER: Chinese builder’s debt struggle rattles investors
Autozone Drives To New High
NASDAQ:IPSC

Century Therapeutics Institutional Ownership

$16.06
+0.35 (+2.23%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.86
▼
$16.97
50-Day Range
$15.23
▼
$25.16
52-Week Range
$14.14
▼
$32.90
Volume
60,870 shs
Average Volume
175,593 shs
Market Capitalization
$877.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Institutional Ownership Changes (13F Filings) for Century Therapeutics (NASDAQ:IPSC)

Current
Institutional Ownership
Percentage
35.23%

Number of
Institutional Buyers
(last 12 months)
37

Total
Institutional Inflows
(last 12 months)
$328.30 M

Number of
Institutional Sellers
(last 12 months)
4

Total
Institutional Outflows
(last 12 months)
$3.42 M

Skip Chart & View Institutional Buying and Selling Data

Institutional Buying and Selling by Quarter


Century Therapeutics (NASDAQ IPSC) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2021American International Group Inc.6,463$0.16M0.0%N/A0.012%
11/18/2021Bank of New York Mellon Corp28,932$0.73M0.0%N/A0.053%
11/16/2021Schonfeld Strategic Advisors LLC13,600$0.34M0.0%-24.9%0.025%
11/16/2021Metropolitan Life Insurance Co NY3,737$94K0.0%N/A0.007%
11/16/2021Millennium Management LLC69,024$1.74M0.0%-61.9%0.127%
11/16/2021Citadel Advisors LLC24,044$0.61M0.0%N/A0.044%
11/15/2021California State Teachers Retirement System6,381$0.16M0.0%N/A0.012%
11/15/2021Marshall Wace LLP111,552$2.81M0.0%+111.5%0.205%
11/15/2021Royal Bank of Canada1,399$35K0.0%N/A0.003%
11/15/2021Morgan Stanley331,869$8.35M0.0%-1.3%0.610%
11/12/2021Ghisallo Capital Management LLC15,000$0.38M0.0%-50.0%0.028%
11/12/2021Parametrica Management Ltd28,755$0.72M0.5%N/A0.053%
11/12/2021Geode Capital Management LLC204,691$5.15M0.0%+429.4%0.376%
11/10/2021Citigroup Inc.1,335$34K0.0%N/A0.002%
11/9/2021BlackRock Inc.648,656$16.32M0.0%N/A1.192%
11/4/2021Deutsche Bank AG6,795$0.17M0.0%N/A0.012%
11/2/2021New York State Common Retirement Fund2,100$53K0.0%N/A0.004%
11/1/2021SG Americas Securities LLC5,314$0.13M0.0%N/A0.010%
10/22/2021Strs Ohio2,700$67K0.0%N/A0.005%
8/25/2021Marshall Wace LLP52,749$1.55M0.0%N/A0.097%
8/25/2021Marshall Wace North America L.P.247,251$7.25M0.0%N/A0.454%
8/23/2021Morgan Stanley336,223$9.87M0.0%N/A0.618%
8/17/2021Woodline Partners LP281,726$8.27M0.2%N/A0.514%
8/17/2021Sphera Funds Management LTD.80,000$2.35M0.2%N/A0.146%
8/17/2021Logos Global Management LP989,095$29.02M2.5%N/A1.804%
8/17/2021Millennium Management LLC181,164$5.32M0.0%N/A0.330%
8/17/2021Octagon Capital Advisors LP403,523$11.84M2.5%N/A0.736%
8/17/2021Caas Capital Management LP30,000$0.88M0.0%N/A0.055%
8/16/2021LMR Partners LLP49,323$1.45M0.0%N/A0.090%
8/16/2021Hhlr Advisors LTD.614,095$18.02M0.2%N/A1.120%
8/16/2021RA Capital Management L.P.914,094$26.82M0.4%N/A1.667%
8/16/2021Tudor Investment Corp Et Al7,000$0.21M0.0%N/A0.013%
8/16/2021Morgan Stanley336,223$9.87M0.0%N/A0.613%
8/16/2021Schonfeld Strategic Advisors LLC18,100$0.53M0.0%N/A0.033%
8/16/2021Pinz Capital Management LP38,500$1.13M0.3%N/A0.070%
8/16/2021Maven Securities LTD48,483$1.45M0.1%N/A0.088%
8/16/2021Federated Hermes Inc.550,000$16.14M0.0%N/A1.003%
8/16/2021Goldman Sachs Group Inc.52,808$1.55M0.0%N/A0.096%
8/13/2021Qube Research & Technologies Ltd19,979$0.59M0.0%N/A0.036%
8/13/2021Geode Capital Management LLC38,668$1.13M0.0%N/A0.071%
8/13/2021Vanguard Group Inc.30,000$0.88M0.0%N/A0.055%
8/13/2021FMR LLC4,959,411$141M0.0%N/A9.046%
8/12/2021Legal & General Group Plc1,000$29K0.0%N/A0.002%
8/12/2021Monashee Investment Management LLC60,000$1.76M0.2%N/A0.109%
(Data available from 1/1/2016 forward)













Century Therapeutics (NASDAQ:IPSC) Institutional Ownership Frequently Asked Questions

Who are the institutional owners of Century Therapeutics?

During the previous two years, 38 institutional investors and hedge funds held shares of Century Therapeutics. The most heavily invested institutionals were FMR LLC ($141M), Logos Global Management LP ($29.02M), RA Capital Management L.P. ($26.82M), Hhlr Advisors LTD. ($18.02M), BlackRock Inc. ($16.32M), Federated Hermes Inc. ($16.14M), and Octagon Capital Advisors LP ($11.84M).Learn more on IPSC's institutional investors

What percentage of Century Therapeutics stock is owned by institutional investors?

35.23% of Century Therapeutics stock is owned by institutional investors. Learn more on IPSC's institutional investor holdings

Which institutional investors have been buying Century Therapeutics stock?

Of the 37 institutional investors that purchased Century Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($4.96M), Logos Global Management LP ($0.99M), RA Capital Management L.P. ($0.91M), Morgan Stanley ($0.67M), BlackRock Inc. ($0.65M), Hhlr Advisors LTD. ($0.61M), and Federated Hermes Inc. ($0.55M).

How much institutional buying is happening at Century Therapeutics?

Institutional investors have bought a total of 11,330,852 shares in the last 24 months. This purchase volume represents approximately $328.30M in transactions.

Which Century Therapeutics institutionals have been selling company stock?

The following institutional investors have sold Century Therapeutics stock in the last 24 months: Millennium Management LLC ($0.11M), Ghisallo Capital Management LLC ($15K), Schonfeld Strategic Advisors LLC ($4.50K), and Morgan Stanley ($4.35K).

How much institutional selling is happening at Century Therapeutics?

Institutional investors have sold a total of 135,994 shares in the last 24 months. This volume of shares sold represents approximately $3.42M in transactions.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.